NCT03021720
- Conditions
- Behavior, Health Behavior, Leiomyoma, +7 more
- Locations
-
- Mount Sinai Hospital Toronto, Ontario, Canada
- University Health Network Toronto, Ontario, Canada
Clinical trial condition
Neoplasms, Connective and Soft Tissue
Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.
2,731 public trials
585 recruiting studies
Neoplasms, Connective and Soft Tissue trial results
NCT02273739
- Conditions
- Adenocarcinoma, Angioimmunoblastic T-cell Lymphoma, Carcinoma, +22 more
- Locations
-
- Los Angeles, California, United States
- Los Angeles, California, United States
- Miami, Florida, United States
- Baltimore, Maryland, United States
NCT01327612
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +44 more
- Locations
-
- Research Site Duarte, California, United States
- Research Site La Jolla, California, United States
- Research Site Denver, Colorado, United States
- Research Site Tampa, Florida, United States
NCT02474576
- Conditions
- Connective Tissue Diseases, Contracture, Dupuytren Contracture, +10 more
- Locations
-
- Diaconesses Croix Saint-Simon Hospital Group Paris, France
NCT03444987
- Conditions
- Leiomyoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- Assiut university -Faculty of medicine- Departement of Biochemistry Asyut, Egypt
NCT02620254
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
- Locations
-
- Registry participation is worldwide and not limited to this facility Cambridge, Massachusetts, United States
Completed
The Hysteroscopic Morcellator (HM).
NCT01537822
- Conditions
- Large Intrauterine Polyps, Myoma, Neoplasms, +5 more
- Locations
-
- Ghent University Hospital Ghent, Belgium
- Catharina Hospital Eindhoven Eindhoven, Netherlands
NCT01833520
- Conditions
- Disease Attributes, Neoplasm Metastasis, Neoplasms, +10 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)
NCT01271712
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- Scottsdale, Arizona, United States
- Evanston, Illinois, United States
- Skokie, Illinois, United States
- Boston, Massachusetts, United States
NCT01840124
- Conditions
- Leiomyoma, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- University of California, Davis Davis, California, United States
- University of California, Irivine Irvine, California, United States
- University of California, San Diego La Jolla, California, United States
- University of California, Los Angeles Los Angeles, California, United States